VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019 01 03; 380(1):11-22.
View in:
PubMed
subject areas
Aged
Cardiovascular Diseases
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Eicosapentaenoic Acid
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertriglyceridemia
Incidence
Kaplan-Meier Estimate
Male
Middle Aged
Platelet Aggregation Inhibitors
Risk Factors
Secondary Prevention
Triglycerides
authors with profiles
CHRISTIE BALLANTYNE